Recent advancements in multiplexed profiling and tissue imaging methods have enabled the assessment of spatial heterogeneity in intact tissues; as a result, adoption of spatial omics solutions offering benefits over traditional methods, is increasing

Currently used histological methods measure limited number of biomarkers at a time and the fluorescent tags introduced interfere with the natural function of genes and proteins. Stakeholders are on the lookout for platforms that can simultaneously capture the arrangement of multiple biomolecules with single-cell or subcellular resolution, while preserving the tissue integrity. The up-and-coming field of spatial biology addresses this unmet need, while bridging the gap between high plex, high throughput, and high resolution.

The financial opportunity within the spatial genomics market has been analyzed across the following segments:

§  Type of Solution

• Instruments
• Consumables
• Services

§  Sample Type

• DNA
• RNA
• Protein

§  Research Area

• Oncological Disorders
• Immunological Disorders
• Neurological Disorders
• Infectious Diseases
• Others

§  End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes

§  Key Geographical Regions 

• North America
• Europe
• Asia-Pacific and Rest of the World

The Spatial Genomics, Transcriptomics and Proteomics Solutions Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:

§  10x Genomics

§  Akoya Biosciences

§  Bruker

§  Canopy Biosciences

§  NanoString Technologies

§  Vizgen

§  Lunaphore Technologies

§  Molecular Machines & Industries (MMI)

§  Resolve Biosciences

Table of Contents

1.  Preface

2.  Executive Summary

3.  Introduction

4.  Spatial Omics Solutions: Market Landscape

5.  Product Competitiveness Analysis

6.  Company Profiles

7.  Partnerships and Collaborations

8.  Patent Analysis

9.  Publication Analysis

10. Case Study on Potential Clients of Spatial Omics Solutions

11. Case Study on Sequencing Techniques

12. Market Sizing and Opportunity Analysis

13. Executive Insights

14. Conclusion

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/spatial-genomics-market.html

You may also be interested in the following titles:

You may also like to learn what our experts are sharing in Roots educational series:

Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com